Selzentry Patient Population Needs Further Definition, Advisory Panel Urges

Determining the effect of Pfizer's Selzentry (maraviroc) in subpopulations of HIV patients was the theme of recommendations by the Antiviral Drugs Advisory Committee for post-marketing studies Oct. 8